BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO)

CUSIP: 10806X102

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
191,564,221
Total 13F shares
184,963,434
Share change
-3,590,755
Total reported value
$9,606,937,258
Put/Call ratio
16%
Price per share
$51.94
Number of holders
389
Value change
-$158,160,333
Number of buys
218
Number of sells
172

Quarterly Holders Quick Answers

What is CUSIP 10806X102?
CUSIP 10806X102 identifies BBIO - BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q3 2025

As of 30 Sep 2025, BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) was held by 389 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 184,963,434 shares. The largest 10 holders included VANGUARD GROUP INC, VIKING GLOBAL INVESTORS LP, BlackRock, Inc., Kohlberg Kravis Roberts & Co. L.P., JANUS HENDERSON GROUP PLC, FARALLON CAPITAL MANAGEMENT LLC, Aisling Capital Management LP, STATE STREET CORP, Invesco Ltd., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 389 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.